Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ER
Acta Pharmaceutica Sinica B
;
(6): 442-455, 2021.
Article
in English
| WPRIM
| ID: wpr-881146
ABSTRACT
Although different types of drugs are available for postmenopausal osteoporosis, the limitations of the current therapies including drug resistances and adverse effects require identification of novel anti-osteoporosis agents. Here, we defined that norlichexanthone (NOR), a natural product, is a ligand of estrogen receptor-alpha (ER
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Acta Pharmaceutica Sinica B
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS